The issue size of the Suraksha Diagnostic Limited IPO is Rs 846.25 crore which comprises an offer for sale (OFS) of 1.91 crore shares, with no fresh issue component.

While Suraksha Diagnostic's revenue growth over the past few years has remained muted, the company's margins have expanded from 28% in fiscal 2022 to 32% in fiscal 2024. The company's net profit has grown at a 5.4% compounded annual growth rate over FY22-24.

Suraksha Diagnostic, the largest full-service integrated diagnostic chain in East India by operating income as of FY23, provides a one-stop solution for pathology and radiology testing, along with medical consultation services.

Suraksha Diagnostic IPO opens for subscription on November 29, offering shares priced between ₹420 and ₹441. The company has a robust operational network with numerous laboratories and performed 1.58 million tests recently,

The initial public offering (IPO) of Suraksha Diagnostic Limited is set to open for bidding on Friday, November 29, 2024. The IPO aims to raise Rs 846.25 crore through an offer for sale (OFS) of 1.92 crore shares.

Suraksha Diagnostics Limited is set to launch its IPO on November 29, 2024, with the subscription period running until December 3, 2024. The company aims to raise Rs.846.25 crores through the IPO, which is an entirely offer-for-sale (OFS) of 1.

The company has set a price band of ₹420-441 per share for its IPO, where investors can bid for 34 shares in one lot and in multiples thereafter. Through this offering, the company aims to raise ₹846 crore.

Suraksha Diagnostic IPO opens on November 29, 2024, with a price band of ₹420-₹441 per share, recommended by Bajaj Broking.

Suraksha Diagnostic IPO comprises an entire offer for sale with promoters, investors, and individual shareholders offloading up to 19,189,330 equity shares of the company. Somnath

The IPO of Suraksha Diagnostic is entirely an offer-for-sale (OFS) of up to 1,91,89,330 equity shares by its promoters and existing shareholders, amounting to Rs 846.25 crore.